Fmoc-[D2]Gly-OH

Fmoc-[D2]Gly-OH is an Fmoc-protected deuterated glycine in which the amino acid backbone bears two deuterium atoms at the alpha position, retaining the amino acid stereochemical identity of glycine as a chiral-center-free scaffold while providing an isotopically labeled reference for mass-based detection. The structure combines an N-(9H-fluoren-9-ylmethoxycarbonyl) carbamate with a free carboxylic acid, enabling standard peptide coupling chemistry while maintaining compatibility with Fmoc solid-phase synthesis workflows. The deuterium substitution alters vibrational and mass signatures without introducing additional reactive side-chain functionality, and the carboxyl group remains available for activation and amide-bond formation. This isotopically labeled, N-protected amino acid is commonly used as a chemically stable intermediate for peptide building block preparation and analytical or mechanistic studies in peptide science and amino acid metabolism research.

1. Isotope-Labeled Peptide Synthesis

Fmoc-[D2]Gly-OH supports isotope-resolved peptide construction for analytical and mechanistic studies, where the Fmoc carbamate enables controlled N-deprotection and the free carboxylic acid enables peptide coupling at the glycine position. The deuterated alpha-carbon increases mass distinguishability of the incorporated residue, allowing LC-MS or MS/MS workflows to track labeled fragments through fragmentation patterns and retention behavior. The absence of a side chain beyond the labeled backbone simplifies interpretation in peptide mapping, making it suitable for building labeled standards, internal controls, and tracer-containing peptide analogs. Downstream, the resulting labeled peptides can serve as reference materials for method development, proteomics workflows, and reaction monitoring in peptide synthesis and biochemical research.

2. Analytical Research Standards

Fmoc-[D2]Gly-OH functions as an amino acid and peptide-level isotope standard precursor because the Fmoc-protected nitrogen and deuterated backbone provide a defined chemical signature that survives derivatization steps used in analytical sample preparation. The carboxyl group and N-protecting group architecture allow incorporation into peptides or conversion into labeled building blocks that can be used to calibrate quantitation and validate analytical selectivity. Deuterium labeling at the glycine backbone can be leveraged to differentiate endogenous or unlabeled species from tracer-containing analytes during mass spectrometric detection. The labeled products derived from this intermediate are therefore applicable to quantitative analytical chemistry, isotope-dilution approaches, and verification of peptide identity in research-grade characterization.

3. Peptidomimetic And Scaffold Labeling

Fmoc-[D2]Gly-OH can be employed in peptidomimetic and molecular scaffold construction where glycine residues act as conformational spacers and coupling handles within larger frameworks. The Fmoc-protected amine supports sequential assembly strategies, while the deuterated backbone enables tracing of synthetic incorporation and can help resolve structure-property relationships by tracking labeled positions in downstream degradation or binding studies. The deuterium substitution can also be used to probe mechanistic aspects of amide-bond formation, cleavage, or metabolic turnover in model systems without changing the core functional groups. The resulting labeled peptidomimetics and scaffold analogs can be used as research intermediates for SAR studies, mechanistic investigations, and synthetic method validation in applied peptide chemistry.

4. Protein Engineering Tracer Building Blocks

Fmoc-[D2]Gly-OH serves as a defined isotopic building block for preparing labeled peptide segments that can be used in protein engineering workflows, including the generation of labeled epitopes for binding studies and protein-peptide interaction mapping. The Fmoc protection strategy supports stepwise assembly of glycine-containing sequences, and the free carboxyl group ensures compatibility with standard coupling chemistries used to generate amide-linked peptide fragments. Deuterium incorporation at the glycine alpha position provides a mass-resolved marker that can be tracked through enzymatic processing, proteolysis, or fragment-based characterization. Labeled fragments derived from this intermediate can therefore support research-grade protein studies, including mapping of modification sites and verification of engineered sequence incorporation.

5. Pharmaceutical Intermediate Preparation

Fmoc-[D2]Gly-OH is suitable for pharmaceutical intermediate preparation when isotopically labeled amino acid residues are required for process development, impurity profiling, or analytical qualification of peptide-containing intermediates. The combination of an Fmoc-protected amine and a free carboxylic acid aligns with common protected amino acid chemistry used in peptide manufacturing routes, enabling incorporation into protected peptide intermediates under controlled deprotection and coupling cycles. The deuterated backbone provides a stable isotopic tag that can distinguish labeled intermediates from unlabeled process streams during method development and characterization. Downstream, labeled peptide intermediates prepared from this compound can be applied to reference standard generation, process monitoring studies, and analytical method transfer for peptide-based chemical manufacturing contexts.

1. C-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients

2. Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma

3. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die

4. Odorant binding protein based biomimetic sensors for detection of alcohols associated with Salmonella contamination in packaged beef

5. Uncarboxylated osteocalcin decreases insulin-stimulated glucose uptake without affecting insulin signaling and regulators of mitochondrial biogenesis in myotubes